“Starting with the first half of June 2026, the Norofert factory in Chapecó, Brazil, is authorized to begin fertilizer production, on which occasion the first quantities will be sent to Brazilian farmers. Obtaining the approval represents an important milestone in the Company’s international expansion strategy and allows Norofert do Brasil LTDA to begin its commercial activity in one of the largest agricultural markets in the world, with an area of over 96 million hectares of arable land,” the company has announced in a statement.
The production facility in Chapecó, with a capacity of 15,000 liters per day, was built according to the same technological concept validated by the implementation in South Dakota, USA, using bacteria produced in the research laboratory in Filipestii de Padure. The total investment in the construction of the factory amounted to EUR500,000 and was financed equally by Norofert S.A. and the Engenutri Group, the two partners holding equal shares in the share capital of Norofert do Brasil LTDA.
Norofert posted about RON3.7 million net profit in 2025, up 16% year-over-year, driven by cost efficiencies and the growing contribution of its U.S. operations. The U.S. subsidiary generated approximately RON1 million of the consolidated net profit. Revenue stood at RON41 million in 2025, down approximately 10% compared with the previous year due to lower volumes on the domestic market, as well as the implementation of a prudent commercial policy focused on high-value-added projects.
NRF shares have traded 23.5% lower over the last year, triggering a market capitalization of RON57 million on the AeRO market of the Bucharest Stock Exchange. The company’s shareholders include investor Marius Alexe, with a 12.8% stake, and Vlad Popescu, the Chairman of the Board of Directors, with 31.4%.